These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26405155)

  • 1. Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia.
    den Hoed MA; Pluijm SM; te Winkel ML; de Groot-Kruseman HA; Fiocco M; Hoogerbrugge P; Leeuw JA; Bruin MC; van der Sluis IM; Bresters D; Lequin MH; Roos JC; Veerman AJ; Pieters R; van den Heuvel-Eibrink MM
    Haematologica; 2015 Dec; 100(12):1564-70. PubMed ID: 26405155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocol.
    te Winkel ML; Pieters R; Hop WC; Roos JC; Bökkerink JP; Leeuw JA; Bruin MC; Kollen WJ; Veerman AJ; de Groot-Kruseman HA; van der Sluis IM; van den Heuvel-Eibrink MM
    Bone; 2014 Feb; 59():223-8. PubMed ID: 24287213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia.
    te Winkel ML; Pieters R; Hop WC; de Groot-Kruseman HA; Lequin MH; van der Sluis IM; Bökkerink JP; Leeuw JA; Bruin MC; Egeler RM; Veerman AJ; van den Heuvel-Eibrink MM
    J Clin Oncol; 2011 Nov; 29(31):4143-50. PubMed ID: 21947829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
    Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early presentation of osteonecrosis in acute lymphoblastic leukemia: Two children from the Nordic and Baltic cohort.
    Mogensen SS; Harila-Saari A; Frandsen TL; Lähteenmäki P; Castor A; Kohonen I; Schmiegelow K; Mäkitie O
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28521072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia.
    Mogensen SS; Harila-Saari A; Mäkitie O; Myrberg IH; Niinimäki R; Vestli A; Hafsteinsdottir S; Griškevicius L; Saks K; Hallböök H; Retpen J; Helt LR; Toft N; Schmiegelow K; Frandsen TL;
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27300. PubMed ID: 29943905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
    van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the Relationship Between
    Erdem M; Tüfekçi Ö; Kızıldağ S; Yılmaz Ş; Kızmazoğlu D; Eroğlu Filibeli B; Ören H
    Turk J Haematol; 2019 Feb; 36(1):12-18. PubMed ID: 30251958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. British OsteoNEcrosis Study (BONES) protocol: a prospective cohort study to examine the natural history of osteonecrosis in older children, teenagers and young adults with acute lymphoblastic leukaemia and lymphoblastic lymphoma.
    Amin N; Kinsey S; Feltbower R; Kraft J; Whitehead E; Velangi M; James B
    BMJ Open; 2019 May; 9(5):e027204. PubMed ID: 31122988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
    Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in bone mineral density during therapy in childhood acute lymphoblastic leukemia.
    Kaushik A; Bansal D; Khandelwal N; Trehan A; Marwaha RK
    Indian Pediatr; 2009 Mar; 46(3):245-8. PubMed ID: 19213989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective bone ultrasound patterns during childhood acute lymphoblastic leukemia treatment.
    Mussa A; Bertorello N; Porta F; Galletto C; Nicolosi MG; Manicone R; Corrias A; Fagioli F
    Bone; 2010 Apr; 46(4):1016-20. PubMed ID: 20044045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
    Mattano LA; Sather HN; Trigg ME; Nachman JB
    J Clin Oncol; 2000 Sep; 18(18):3262-72. PubMed ID: 10986059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia.
    Halton JM; Atkinson SA; Fraher L; Webber C; Gill GJ; Dawson S; Barr RD
    J Bone Miner Res; 1996 Nov; 11(11):1774-83. PubMed ID: 8915786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia.
    Tillmann V; Darlington AS; Eiser C; Bishop NJ; Davies HA
    J Bone Miner Res; 2002 Jun; 17(6):1073-80. PubMed ID: 12054163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Skeletal-related side effects of acute lymphoblastic leukemia treatment in children].
    Beniczky NJ; Hosszú É; Erdélyi DJ; Müller J; Jakab Z; Kovács G
    Orv Hetil; 2020 Dec; 161(49):2086-2093. PubMed ID: 33279884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density in children with acute lymphoblastic leukemia.
    Inaba H; Cao X; Han AQ; Panetta JC; Ness KK; Metzger ML; Rubnitz JE; Ribeiro RC; Sandlund JT; Jeha S; Cheng C; Pui CH; Relling MV; Kaste SC
    Cancer; 2018 Mar; 124(5):1025-1035. PubMed ID: 29266176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of bony morbidity in children with acute lymphoblastic leukemia.
    Rayar MS; Nayiager T; Webber CE; Barr RD; Athale UH
    Pediatr Blood Cancer; 2012 Jul; 59(1):77-82. PubMed ID: 22190454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia.
    Jain S; Jain S; Kapoor G; Virmani A; Bajpai R
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27671543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
    Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
    Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.